Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Repligen Corp (NQ: RGEN ) 133.06 -1.94 (-1.44%) Streaming Delayed Price Updated: 11:40 AM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Repligen Corp < Previous 1 2 3 4 5 6 Next > Stocks That Hit 52-Week Highs On Friday August 20, 2021 Before 10 a.m. ET on Friday, 52 companies hit new 52-week highs. Highlights: Microsoft (NASDAQ:MSFT) was the biggest company by market cap to set a new 52-week high... Via Benzinga Stocks That Hit 52-Week Highs On Wednesday August 18, 2021 Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs. Areas of Significance: Pfizer (NYSE:PFE) was the largest firm on a market cap basis to set a new... Via Benzinga The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO August 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... Via Benzinga Stocks That Hit 52-Week Highs On Thursday July 29, 2021 Thursday's morning session saw 167 companies set new 52-week highs. Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by market cap to set a new... Via Benzinga Tandem Diabetes Care Stock Sees Improved Relative Strength August 16, 2021 The Relative Strength (RS) Rating for Tandem Diabetes Care stock moved up into a higher percentile Monday, as it got a lift from 68 to 73. Via Investor's Business Daily The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts August 10, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... Via Benzinga Exposures COVID-19 Earnings Scheduled For July 27, 2021 July 27, 2021 Companies Reporting Before The Bell • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on revenue of $146.03 million.... Via Benzinga The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering August 11, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... Via Benzinga Exposures Product Safety Stocks That Hit 52-Week Highs On Tuesday August 10, 2021 Before 10 a.m. ET on Tuesday, 100 stocks hit new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was Pfizer (... Via Benzinga Staar Surgical Stock Scores Relative Strength Rating Upgrade August 06, 2021 Staar Surgical stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an increase from 89 to 95. Via Investor's Business Daily The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business August 03, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... Via Benzinga The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO August 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... Via Benzinga The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings August 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... Via Benzinga Why Repligen Stock Soared This Week July 30, 2021 The life sciences company reported better-than-expected second-quarter results. Via The Motley Fool The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs July 29, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety Is It Too Late to Buy Moderna Stock? July 29, 2021 Moderna Inc. stock skyrocketed last year, moving over 434% on global demand for coronavirus vaccines. The question now is whether it can continue to rally higher, with or without COVID-19. Via Talk Markets Exposures COVID-19 62 Biggest Movers From Yesterday July 28, 2021 Gainers Intrusion Inc. (NASDAQ: INTZ) shares surged 52.1% to settle at $5.14 on Tuesday. Intrusion recently issued worse-than-expected preliminary Q2 sales results and announced... Via Benzinga Repligen Corp (RGEN) Q2 2021 Earnings Call Transcript July 27, 2021 RGEN earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Recap: Repligen Q2 Earnings July 27, 2021 Shares of Repligen (NASDAQ:RGEN) moved higher by 0.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 88.10% over... Via Benzinga Earnings Outlook For Repligen July 26, 2021 Repligen (NASDAQ:RGEN) announces its next round of earnings this Tuesday, July 27. Here is Benzinga's everything-that-matters guide for this Tuesday's Q2 earnings announcement.... Via Benzinga 3 Healthcare Stocks to Buy and Hold for the Next 10 Years July 22, 2021 Don't overthink it -- buy companies with excellent financials and a long runway for growth. Via The Motley Fool Repligen To Buy Polymem For An Undisclosed Sum June 22, 2021 Repligen Corporation (NASDAQ: RGEN) has agreed to acquire France-based Polymem S.A., a provider of hollow fiber membranes and modules. "The acquisition... Via Benzinga Repligen Joins Elite List Of Stocks With 95-Plus Composite Rating June 18, 2021 The new score means Repligen is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria. Via Investor's Business Daily Exposures COVID-19 Repligen Corp (RGEN) Q1 2021 Earnings Call Transcript May 04, 2021 RGEN earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial Dow Jones Hits High As Metals, Miners, Fertilizers Thrive, But Growth Stocks Slump; Jobs Report Stunningly Weak May 07, 2021 The Dow hit highs but growth stocks slumped, despite a Friday bounce on weak jobs gains. Miners, metals, fertilizers thrived. Via Investor's Business Daily Topics Economy Intellectual Property Stocks Exposures COVID-19 Intellectual Property Interest Rates Repligen Earnings Double As Sales Growth Accelerates; RGEN Stock Nears Buy Point May 04, 2021 Repligen earnings shot up 113% in Q1 with sales growth accelerating to 88%. The biotech raised full-year guidance. RGEN stock rose, nearing a buy point. Via Investor's Business Daily Repligen: Q1 Earnings Insights May 04, 2021 Shares of Repligen (NASDAQ:RGEN) moved higher by 7.5% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 112.50% over... Via Benzinga The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data May 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 04, 2021 Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 65.2% to $5.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $226.7... Via Benzinga Earnings Scheduled For May 4, 2021 May 04, 2021 Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million. •... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.